Nordic Bioscience Revenue and Competitors

Herlev,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Nordic Bioscience's estimated annual revenue is currently $37.8M per year.(i)
  • Nordic Bioscience's estimated revenue per employee is $155,000

Employee Data

  • Nordic Bioscience has 244 Employees.(i)
  • Nordic Bioscience grew their employee count by 0% last year.

Nordic Bioscience's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is Nordic Bioscience?

Nordic Bioscience is the leading expert in extracellular matrix (ECM) with 25+ years of experience in biomarker development, clinical and pre-clinical research. Fragments form the reactive stroma and ECM have been identified by the research team at Nordic Bioscience and corresponding quantification assays have been developed in parallel. By quantifying stromal reactivity we are able to provide true predictive value and we can select the patients most likely to respond to a given treatment. It is headquartered in Herlev, Denmark and employs more than 180 people who are dedicated to improve management of patients from a broad range of therapeutic areas including arthritis, oncology, fibrosis and certain neurodegenerative conditions including Alzheimer's.

keywords:N/A

N/A

Total Funding

244

Number of Employees

$37.8M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Nordic Bioscience News

2022-04-06 - Disturbance and breakdown' of cartilage holds clues to ...

... for biomarkers in OA,” Christian Thudium, PhD, MSc, of the department of rheumatology at Nordic Bioscience, in Denmark, told attendees.

2022-03-22 - Endotrophin May Predict Adverse Outcomes After AKI

... which is associated with patient outcome,” Nadja Sparding, PhD, of Nordic Bioscience, Denmark, and colleagues wrote in Kidney360.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$59M2449%N/A
#2
N/A245-1%N/A
#3
$49.8M2636%N/A
#4
$106.7M316-1%N/A